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Retrospective correlation of clinical and histologic findings of
189 exchanged kidneys. Tissues samples from 189 unsuccessful
renal allografts, 47 recovered at autopsy and the others removed
surgically, were examined histologically by light microscopy.
Tissues samples were obtained from cadaver kidneys that had
been exchanged regionally for transplantation. Each allograft tis-
sue sample was rated as to extent of pathologic changes denoting
rejection and was classified accordingly. Surgical and autopsy
reports, as well as clinical data, were then obtained and these
were compared with the retrospective pathologic findings of
this study. Our pathologic findings agreed with the original patho-
logic diagnosis as to presence or absence of rejection changes in
180 cases, but disagreed with the clinical diagnosis of rejection in
28 of the 63 cases with minimal orno histologic evidence of rejec-
tion. There was less disagreement with the clinical diagnosis for
the 87 cases with histologic evidence of rejection which had been
judged as sufficient to cause allograft loss, 70 having been clini-
cally diagnosed as rejected. Disagreement occurred most often
where the allograft had never functioned or had been lost within
3 months. Retrospective analysis did not disclose any associa-
tion between rejection histology and preformed antibodies or
length of kidney perfusion time. Sufficient allografts appeared to
have been lost for reasons other than rejection to cast doubt on
the validity of interpreting renal allograft data only by graft sur-
vival statistics.
sants pour determiner Ia perte du greffon, 70 d'entre eux avaient
eté l'objet d'un diagnostic clinique de rejet. Le désaccord ëtait
plus important quand lagreffe n'avaitjamais fonctionné ou avait
perdu sa fonction en moms de trois mois. L'analyse rëtrospec-
tive n'a pas mis en evidence d'association entre l'histologie de
rejet et les anticorps antérieurement presents ou Ia duree de la
perfusion rénale. Un nombre suffisant de greffes semble avoir
été perdu pour des causes autres que le rejet pour qu'un doute
existe a propos de Ia validité de l'interprétation des résultats de
Ia greffe rénale seulement par les statistiques concernant la sur-
vie du greffon.
The Southeastern Regional Organ Procurement
Program1, a group of hospitals that exchanges ca-
daver kidneys for transplantation, initiated in 1972 a
system for centralized histologic examination and
review of those allografts which had been lost by
death of the recipient or by surgical excision. This
study had two purposes: to establish relatively uni-
form criteria for evaluating the morphologic find-
Correlation retrospective entre les constatations cliniques et his-
tologiques a propos de 189 reins retires après transplantation. Des
échantillons de 189 transplants rénaux ayant échoué (47 reins
preleves a l'autopsie et les autres chirugicalement) ont été cx-
aminés en microscopie photonique. Du tissu renal a été prélevd
sur des reins de cadavres transplantés en échange des précé-
dents. Chaque allogreffe a eté évaluée en cc qui concerne les
modifications pathologiques traduisant un rejet et classée en fon-
ction de ces critères. Les dossiers chirurgicaux et autopsiques,
ainsi que les informations cliniques, ont alors été considérés et
compares avec les constatations morphologiques retrospectives
de cette étude. Nos constatations morphologiques étaient en ac-
cord avec le diagnostic anatomo-pathologique initial en ce qui
concerne Ia presence ou l'absence de rejet dans 180 cas, mais en
désaccord avec Ic diagnostic clinique de rejet dans 28 cas sur 63
ou les signes histologiques de rejet etaient minimes ou absents.
Le désaccord était moindre avec Ic diagnostic clinique pour les
87 cas comportant des signes histologiques de rejet jugés suffi-
559
'The program began as an informal regional group of physi-
cians representing 9 member hospitals in 1968, was officially es-
tablished in 1975, and later changed its name to Southeastern
Organ Procurement Foundation (SEOPF). The 34 current full
member hospitals have teletype connections to a central comput-
er. Sera from patients awaiting kidney transplants are cross-
matched and distributed to participating transplantation groups.
Available kidneys are supplied on the basis of crossmatch data
and computerized information.
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ings, and to compare retrospectively the morpho-
logic and clinical data on the allografts. In addition,
such related data as perfusion, presence or absence
of antibodies, antigen match, function and length of
survival of the allografts were assessed.
Methods
All kidneys had been obtained from cadavers that
had been exchanged between member institutions
for transplantation during the period 1968 to 1975
and subsequently had been recovered either by sur-
gical excision or, in 47 of the 189 cases, at autopsy.
Tissues samples from these allografts were obtained
as wax blocks, unstained slides, and, in some in-
stances, original slides. The blocks were cut at 2 to
3 and stained with hemotoxylin eosin, methamine
silver (Jones method), and periodic acid Schiff
(McManus method).
Available material did not permit the utilization
of immunofluorescent or electron microscopy tech-
niques. All evaluations were limited to light micros-
copy. All tissues were examined morphologically
and histologically by a reviewing pathologist whose
only knowledge of the recipient's clinical course
was that the allograft had been lost or that the pa-
tient had died.
The findings of the authors are based on those
data afforded by the study's examining patholo-
gist's histologic examination of the tissues sub-
mitted by the contributing transplantation center,
information provided by SEOPF central office or
appropriate tissue typing laboratories, the autopsy
and surgical reports, and the replies to the question-
naires sent out on each case. Sixteen different insti-
tutions participated in this study.
Morphological evaluation. The following mor-
phology was evaluated for rejection changes: (a) the
degree of cellular infiltration, if any, the cell type of
infiltrate found, as well as the focal or diffuse nature
of that infiltrate; (b) the degree of vascular change,
if any, i.e., thickening or intimal swelling, cellular
proliferation and/or necrosis of the vessel walls; (c)
the degree of glomerular changes, if any, i.e., mem-
brane changes, hyalinization and/or cellular infil-
tration; (d) the degree of tubular changes, if any,
i.e., tubular necrosis, cellular infiltration, basement
membrane alteration, and/or interstitial fibrosis.
Cellular, vascular, glomerular, and tubular
changes were each evaluated separately, and then
each was rated subjectively for its degree of rejec-
tion change on a graduated scale from #0 to #5.
Assignment of the ratings was as follows: 0, no dis-
cernible change; 1, minimal changes; 2, moderate
changes but insufficient to warrant pathologic diag-
nosis of rejection; 3, equivocal changes possibly
warranting pathologic diagnosis of rejection; 4,
marked changes; and 5, severe changes of rejection.
Determination and classification of rejection
type. A decision was then made in each case as to
whether the observed changes and lesions were suf-
ficient to account for loss of the transplant or failure
of the allograft. This study did not consider a kidney
as lost to rejection unless at least one of the above
morphologic areas showed sufficient degree of
change as to have been assigned to the rating of 4
(marked morphologic changes of rejection) or 5 (se-
vere morphologic changes of rejection). Ratings be-
low 3 were considered negative, and those above
that rating were considered positive for a pathologic
diagnosis of rejection.
In the equivocal category (#3) were three types of
cases: (1) cases of borderline pathologic evidence of
rejection which presented histologic evidence of re-
jection but to a degree insufficient for the examining
pathologist to declare with assurance that the
changes were adequate to explain the failure of the
kidney; (2) cases complicated by evidence of other
disease processes which either obliterated or con-
fused histologic interpretation of the rejection process-
es or represented pathologic processes whose re-
lation to rejection was unclear; and (3) totally in-
farcted kidneys where, without clinical information,
histologic evaluation could contribute little toward
explaining the underlying cause of kidney loss. In
cases of partially infarcted kidneys with apparently
viable areas, morphologic changes in the viable
areas were evaluated and classified accordingly.
Finally, for each kidney the rejection process it-
self was considered and classified as either hyper-
acute (immediate), acute (accelerated), modified
acute (intermediate), or chronic rejection. These
classifications were determined as follows: Hyper-
acute (immediate) rejection: (I) cellular infiltration
mild, primarily neutrophils; (2) fibrin thrombi,
platelet thrombi; (3) variable degree of infarction
and necrosis. Acute (accelerated) rejection: (1) cel-
lular infiltration massive with varying distribution of
lymphocytes, mononuclear cells, plasma cells; (2)
necrosis of vessel walls, thrombi; (3) focal base-
ment membrane destruction of tubules and their
cellular infiltration. Modified acute (intermediate)
rejection: (1) cellular infiltration, particularly pen-
vascular and vessel-wall involvement —primarily
lymphocytes, mononuclear cells, and variable num-
ber of plasma cells: (2) necrosis of arterioles; (3)
thrombi, with or without focal infarction; (4) intima
usually edematous, thickening of intima by varying
deposits of amorphous material, some cellular infil-
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Table 1. Retrospective pathologic diagnosis based on pathologic evidence of rejection in tissue from 189 unsuccessful renal allografts
without reference to clinical data
Pathological diagnosis
No. of allografts
Total Removed surgically Recovered at autopsy
Rejected 87 79 8
Equivocal
Histologically 25 17 8
Infarcted 16 13 3
Minimal orno evidence of rejection 61 33 28
Total 189 142 47
tration in the intima; (5) glomeruli-thickening of
basement membrane; (6) tubules-destruction of
basement membrane and cellular infiltration.
Chronic rejection: (1) predominant vascular
changes in the intima (sub-intima), thickening; (2)
glomeruli-thickened basement membrane, scle-
rosed glomeruli; (3) cellular infiltration variable,
possibly minimal; (4) interstitial fibrosis with re-
placement of tubules.
Clinical data. After the classification of patholog-
ic findings, clinical data were obtained for each kid-
ney. These included information from trans-
planation centers on HLA antigens and recipients'
antibodies, autopsy and surgical reports, and re-
plies from attending physicians to the following
questionnaire:
I. Functional status of kidney transplant*:
a. Never functioned _____________________________
b. Functioned, then stopped
c. Functioning at removal of kidney or death of recipi-
ent
II. If kidney failed before death or removal, give cause of
failure:
a. Rejection
b. Arterial occlusion _________________________
c. Venous occlusion _____________________________
d. Local infection _______________________________
e. Other ____________________________________________
III. If kidney was removed, what was the cause? Specify
clinical reason:
a. Cessation of function _________________________
b. Urinary leakage
c. Hemorrhage from kidney
d. Local infection _____________________________
e. Systemic infection ___________________________
IV. Was systemic infection present?
a. Cytomegalic or other viral infection
b. Fungus Pneumocystis carinii _____________
c. Other Please specify
V. Was kidney perfused on a machine?
a. No.
b. Under 24 hours ________________________________
c. Over 24 hours __________________________________
* Sufficient function that dialysis was unnecessary.
The pathologic findings were then compared sep-
arately with the data from clinicians, the surgical
and autopsy reports, and the data from trans-
planation centers. Statistical analysis was not un-
dertaken. It was felt by the authors that the small
number of cases involved in each group and the nec-
essarily tenuous nature of subjective ratings would
tend to render degrees of significance misleading
and largely academic.
Results
The reviewing pathologist of this study diagnosed
87 allografts as having been lost to rejection process-
es, 41 as equivocal, and 61 as having insufficient re-
jection pathology to account for loss of the allo-
graft (Table I). The 142 allografts that had been sur-
gically removed included 33 with either minimal or
no rejection pathology.
The allografts considered to have been rejected
on the basis of retrospective pathologic examina-
tion of their tissues included 4 classified as hyper-
acute, 11 classified as acute, 35 classified as modi-
fied acute, and 37 classified as chronic rejection.
The clinical diagnosis for 17 of these 87 allografts
had not been that of rejection, 12 of them having
been surgically removed for other reasons (Tables 2
and 3). The clinical diagnosis, however, agreed with
the pathologic diagnosis in 80.5% of these 87 cases,
and in 84.8% of those removed surgically (Table 2).
For the 61 allografts found to have no rejection
pathology, or insufficient pathology to account for
loss of the allograft, there was considerably less
agreement with the clinical diagnosis (Table 4). A
total of 26 had been clinically diagnosed as rejected,
and 19 of these had been surgically removed for that
reason. Of these 19 kidneys, 5 had never functioned
and the other 14 had stopped functioning before
their removal (Table 5). Further analysis of these
cases by the reviewing pathologist revealed that ei-
ther sufficient pathologic changes other than those
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Table 2. Comparison with clinical diagnosis for 87 renal allografts pathologically diagnosed as rejected
Clinical Diagnosis
No. of allografts
Total Removed surgically Recovered at autopsy
Rejected
Not rejected
70
17
67
12
3
5
Agreement with pathologic diagnosis 80.5% 84.8% 37.5%
Table 3. Kidneys removed surgically for various cIinical indications (not rejection) and pathologic evidence of rejection found
Classification
of observed Survival
Pa- pathologic post- Perfused Never Stopped
tient changes of transplant over func- func- Functioning Septi-
no. rejection' months 24 hr. tioned tioning on removal cemia Clinical reason for removal
1 Chronic vascular 12 X Hemorrhage from kidney
2 Accelerated 1 x Rupture of kidney, hemor-
rhage, urinary leakage
3 Accelerated 1 X No function
4 Accelerated 1 X Acute tubular necrosis,
failure to function,
local infection
5 Chronic 1 X X X Systemic infection
6 Intermediate 1 X Hemorrhage from
anastomosis, local infection
7 Chronic 2 X X Systemic infection
8 Intermediate 1 X No function
9 Intermediate 6 X X Arterial occlusion
10 Chronic 6 X X Urinary leakage
11 Chronic 1 X X Failure to function
12 Chronich I X X X Technical problem
Total 4 7 3 2 4
a Histologic findings of rejection were considered adequate to explain loss of kidney.
Previous disease of nephrosclerosis may have existed in donor kidney.
of rejection or additional clinical information could
account for the failure of these allografts (Table 5).
The reviewing pathologist's "equivocal" desig-
nation applied to 16 allografts found to be infarcted
and to 25 that were histologically equivocal as to
rejection. A total of 24 of these, 9 of them infarcted,
had been clinically diagnosed, however, as rejected
(Table 6). Pathology other than rejection changes
found in the equivocal allografts included, in addi-
tion to infarction, pyelonephritis and papillary or
cortical necrosis (Table 7).
There was very good agreement between the re-
viewing pathologist's reports as to the presence or
absence of rejection changes and the pathologic ob-
servations cited in surgical and autopsy reports.
They agreed for 180 of the 189 allografts (95.2%),
although for 8 of these 180, our reviewing patholo-
gist felt the observed rejection changes to be in-
sufficient to explain allograft loss.
Attempts were made in this study to associate
evidence of allograft rejection with pulsatile per-
fusion of the kidney before transplantation, HLA
histocompatability data, and the recipients' per-
centage of preformed antibodies at the 5% and 10%
levels. No significant relationships were found, al-
though 3 of the 4 cases of donor-recipients with 4
antigen matches showed only minimal histologic
evidence of rejection.
Only 92 of the 189 allografts studied had survived
longer than 1 month, and only 5 longer than 1 year.
The discrepancy between clinical diagnosis of rejec-
tion and pathologic evidence of rejection was great-
est for those allografts lost within a month.
Nonfunctional grafts also presented serious prob-
lems in correlating clinical diagnosis with patholog-
ic findings. There were 48 cases in which the trans-
planted kidneys never functioned following trans-
plantation (Table 8). Of these kidneys, 8 were
infarcted, and 21 had been perfused over 24 hours.
It should be noted, however, that of the 178 cases
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Table 4. Comparison with clinical diagnosis of 61 unsuccessful renal allografts pathologically diagnosed as not rejected
No. of allografts
Clinical diagnosis Total Removed surgically Recovered at autopsy
Rejected 26 19 7
Not rejected 35 14 21
Agreement with pathologic diagnosis 57.4% 42.4% 75.0%
Table 5. Kidneys surgically removed for clinical rejection without observed confirmatory pathologic changes
Pa- Observed Post- Perfused Never Stopped
tient pathologic changes transplant over func- func- Septi- Additional
no. of rejectiona Other pathology months 24 hrs tioned tioning cemia clinical information
I Chronic (mild) 2 X
2 Absent 1 X Accidental irrigation
with hypertonic
Collins solution
3 Intermediate (absent-mild) I X Renal hemorrhage
4 Intermediate (absent-mild) 1 X X X Renal hemorrhage, local
infection
5 Intermediate (mild) Venous thrombosis 2 X X
Hemorrhagic infarction
6 Intermediate (mild) Venous thrombosis, acute 1 X X
peripelvic inflamation
7 Absent Pyelonephritis, severe 7 X X X
8 Absent Papillary necrosis I X X
9 Intermediate (mod.) ATNb 3 X Renal aneurysm
10 Intermediate (mild-mod.) Focal abscess pyelo- 1 X
nephritis & hilar venous
thrombosis
11 Intermediate (mild-mod.) ATNb partial infarction I X
12 Intermediate (mild) Partial infarction 1 X
13 Intermediate (mild) Papillary necrosis 3 X X
14 Intermediate (mild) ATNb focal infarction 1 X X Ruptured kidney
15 Intermediate (mild) Glomerulonephritis 8 X Pancreatitis
16 Intermediate (mod.) Cortical necrosis 1 X X Peritonitis, DICe
Pyelonephritis
17 Intermediate (mild) ATNb focal infarction 1 X Local infection, renal
artery hemorrhage
pneumocystis, ATNb
18 Intermediate (mild) Necrosis renal artery 1 X X Staphylococcus pneu-
with hemorrhage monia
19 Intermediate (mild) Pyelonephritis with mycotic 2 X X X Urinary leakage
infection
a None of the rejection changes were considered adequate to explain the loss of the kidney.
b Acute tubular necrosis
Disseminated intervascular clotting
providing perfusion information, 39% of the kid-
neys had received perfusion for over 24 hours.
Discussion
Our results, as well as those of other published
work [1], have convinced us that there is every rea-
son to believe that the severity of the pathologic
changes of rejection can be correlated with the clini-
cal findings of rejection. This association should be
particularly valid for all but that small group of renal
transplant patients whose pathologic findings lie
within the area of borderline rejection changes (Ta-
bles 6 and 7). Acceptance of the premise that there
are occasional borderline cases which necessitate
an equivocal diagnosis by the pathologist is, of
course, a necessary condition to clinician con-
fidence in this or any other grading system.
It is recognized that the pathologic changes of re-
jection could be confused with or modified by acute
interstitial nephritis or recurrence of certain forms
of glomerulonephritis. Such conditions might mimic
or alter the pathologic changes of rejection, but the
clinical data of our study did not support such ex-
planation.
Additionally, the statistical shortcomings of as-
signing quantitative units of "measurement" to
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Table 6. Comparison with clinical diagnosis for 41 unsuccessful renal allografts pathologically diagnosed equivocal as to rejection
Number of allografts
Histologically equivocal Infarcted
Clinical diagnosis Total Removed surgically Recovered at autopsy Total Removed sugically Recovered at autopsy
Rejected 15 12 3 9 7 2
Not rejected 10 5 5 7 6 1
Table 7. Pathology of4l unsuccessful renal allografts classified as equivocal
Dominant pathology
Number of allografts
Removed surgically Recovered at autopsy Total
Infarction 13 3 16
Infection (pyelonephritis) 4 0 4
Papillary necrosis 0 1 1
Cortical necrosis 2 1 3
Borderline histologic rejection 10 6 16
Other 1 0 1
Total 30 ii 4!
subjectively determined intervals of observation are
well recognized. In this study, pathologic processes
are subjectively graded from I to 5 in terms of the
degree of their severity; there is no implication that
these grading intervals are equal units of measure-
ment. It should also be emphasized that, in the in-
terest of objectivity, the pathologic evaluation was
performed "blind," the evaluating pathologist as-
sessing the material without clinical knowledge of
the patient's history or disease progress.
Agreement between the pathologists of the con-
tributing institutions and the reviewing pathologist
of this study was unusually good in the observed
morphologic findings on the tissues submitted. As
far back as the early cases of 1969, the contributing
pathologists described the lesions of rejection even
when they did not use the diagnosis of "rejection"
and chose only to submit a description of their ob-
servations. In most instances the contributing insti-
tutions' pathologists did not attempt to grade or rate
the severity of the rejection phenomenon observed,
nor did they attempt usually to relate the degree of
the observed pathologic changes to the clinical as-
pects of rejection.
In this study, there is good agreement (84.8%) be-
tween the pathologic findings and clinical diagnosis
for those surgically removed allografts with rejec-
tion pathology, although 12 of the 79 had been re-
moved for clinical reasons other than rejection. It is
possible that underlying rejection processes ac-
counted for the clinical findings leading to removal
of the allografts, and it is debatable that any of them
could have been salvaged had it been known that
rejection was occurring. This positive correlation of
pathologic and clinical diagnosis might have been
modified had the time at which the clinical diagnosis
was established been determined. The information
provided by the clinical questionnaire, however,
was obtained several months after the transplant
had been removed.
It is unfortunate that no biopsy material could be
included in this study. The results strongly suggest
that needle biopsy, as practiced at some trans-
plantation centers [2], would avert over-treatment
of rejection symptoms. Also, greater use of needle
biopsy for diagnosis in those cases of rejection
where clinical indications are equivocal would as-
sure prompt treatment of the rejection process.
For those allografts surgically removed because
of a clinical diagnosis of rejection but found to have
only minimal rejection pathology, several ex-
planations are possible. High doses of steroids and
local irradiation could have arrested the rejection
process, thus modifying the subsequent histologic
picture, or histology not ordinarily associated with
rejection might actually have been based on the re-
jection process. An example is segmental in-
farction, with relative sparing of noninfarcted areas;
this is always difficult to explain, and could have
represented unsuspected rejection processes direct-
ed at segmental arteries. A third possible ex-
planation for clinical diagnosis of rejection not con-
firmed pathologically is, of course, inaccurate clini-
cal diagnosis. It should be noted that the 16
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Table 8. Analysis of kidneys that never functioned
.
Pathologic changes
of rejection
Clinica
—_________
I diagnosis
Rejection Nonrejection Total
Rejection 13 8 21
Equivocal:
Histologically 2 2 4
Infarction 4 4 8
Minimal evidence of rejection 6 9 15
Total 25 23 48
different institutions participating in this study had
varying degrees of transplantation experience and
submitted a variable number of cases.
Morphologic changes other than those of rejec-
tion were sufficient to account for loss of renal func-
tion by 15 of the 19 allografts surgically removed as
rejected but having only minimal rejection histolo-
gy. Most noteworthy was evidence of significant in-
fection, varying from papillary necrosis (2 cases) to
severe pyelonephritis (4 cases). It should also be
noted that 12 of these allografts had been removed
within a month of transplantation, a period when
technical problems can easily be confused with the
rejection process. Further, many of the allograft re-
cipients suffered from other debilitating processes
such as infected or hemorrhaging allografts. Their
removal was thus not simply based on a diagnosis of
irrevocable rejection. In 13 of the allografts, how-
ever, there was pathologic evidence of processes at
least underestimated by the clinician. Some of
these, even papillary necrosis, could have been par-
tially due to rejection, but the magnitude of the pa-
thology suggests that if the pathologic processes
had been suspected, the recipient could have been
managed differently. It should be stressed, nonethe-
less, that in all but one of these allografts surgically
removed as rejected, either the pathology or addi-
tional clinical information adequately explained the
loss of function (Table 5).
It may be argued that, for some allograft recipi-
ents, mild rejection histology could have evoked
disproportionate clinical symptoms. Other investi-
gators who used pathologic criteria similar to ours,
however, cited their usefulness not only to establish
a diagnosis of rejection, but to identify allograft re-
cipients potentially responsive to standard immuno-
suppressive treatment [1].
Several recent studies suggest that those cellular
changes commonly accepted as indicating rejection
may not actually reflect the morbid processes that
injure kidneys. Most relevant are experiments in-
volving enhanced allografts in rats; the only
changes distinguishing the enhanced grafts from
those which subsequently stopped functioning were
vascular ones, not the degree or type of cellular in-
filtration [3, 4]. In our study, cellular infiltration was
significant in evaluating rejection pathology. On the
chance that we had misinterpreted the significance
of such infiltration, we analyzed the 11 allografts
evaluated by our study as acute rejection. Clinical
data supported our evaluation for 8 of those allo-
grafts. The other 3 had never functioned and could
have been clinically misdiagnosed. At any rate, it
seems reasonable to conclude, at least within the
limits of our study, massive cellular infiltration was
related to allograft loss.
Although for working purposes we have included
infarcted kidneys in the equivocal group of histolog-
ically indefinable cases, analysis of this entire group
shows no particular trend (Table 7). It is of interest
that, of the study's total of 189 cases, only 16 cases
showed those borderline (3 +) changes of rejection
which necessitated an equivocal histologic classifi-
cation. Infarcted kidneys were classified as equivo-
cal because there was no histologic evidence for de-
termining the pathologic cause of the infarction. It
is interesting that 7 of the 13 surgically removed in-
farcted kidneys had been clinically diagnosed as
lost to rejection, and the other 6 as lost to other clin-
ical processes. Other investigators have noted that
lesions of such nature and degree as we evaluated
as either hyperacute or acute rejection may prog-
ress to infarction [5].
Allografts which never function present an ex-
tremely difficult problem for clinical diagnosis. Of
the 48 we studied, 21 had histologic evidence of re-
jection, and 8 others had infarcted. Clinical diagno-
sis agreed with the pathology in barely 60% of these
cases (Table 8).
It has been suggested that preservation of kid-
neys by pulsatile perfusion increases the incidence
of rejection [6]. Although we found little relation-
ship between the kidney's histologic evidence of re-
jection and its length of perfusion time up to 24
hours, there was some tendency for minimal histo-
logic evidence of rejection, infarction and failure to
function at all among surgically excised kidneys
perfused for over 24 hours. This tendency might
well be expected from the literature on kidney per-
fusion. Some of our kidneys were possibly perfused
for well over 48 hours, in which event one would
expect even poorer function [7].
The failure to find a higher incidence of patholog-
ic rejection in those patients with percent reactive
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antibodies greater or less than either the 5%or 10%
levels may speak well for the crossmatch procedure
used by SEOPF [8]. Considerable effort has been
made by SEOPF to standardize this procedure [9].
It is also of interest to note that the incidence of
infarcted kidneys did not alter with percent reactive
antibodies at either the 5% or 10% levels. The de-
gree of histocompatibility shared between donor
and recipient showed no association with the histo-
logic appearance of the excised grafts of our study.
Unfortunately, the number of cases was too small in
the 4-antigen-match group to draw any conclusions.
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